|
Multiple sclerosis
Citations 351-360 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
- David Pitt, Iris E. Nagelmeier, Heather C. Wilson, and Cedric S. Raine
Neurology 2003; 61: 1113-1120.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Smoking is a risk factor for multiple sclerosis
- Trond Riise, Monica W. Nortvedt, and Alberto Ascherio
Neurology 2003; 61: 1122-1124.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography
- T. C. Frohman, E. M. Frohman, P. O’Suilleabhain, A. Salter, R. B. Dewey, Jr., N. Hogan, S. Galetta, A. G. Lee, D. Straumann, J. Noseworthy, D. Zee, J. Corbett, J. Corboy, V. M. Rivera, and P. D. Kramer
Neurology 2003; 61: 848-850.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Fatigue in MS is related to sympathetic vasomotor dysfunction
- P. Flachenecker, A. Rufer, I. Bihler, C. Hippel, K. Reiners, K.V. Toyka, and J. Kesselring
Neurology 2003; 61: 851-853.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Is multiple sclerosis still a clinical diagnosis?
- Jack H. Simon and Alan J. Thompson
Neurology 2003; 61: 596-597.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Botulinum toxin treatment of painful tonic spasms in multiple sclerosis
- D. A. Restivo, M. Tinazzi, F. Patti, A. Palmeri, and D. Maimone
Neurology 2003; 61: 719-a-720-a.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
A rare, treatable cause of relapsing encephalopathy in an MS patient on interferon beta therapy
- Chris H. Polman, Paul H.P. Jansen, Cees Jansen, and Bernard M.J. Uitdehaag
Neurology 2003; 61: 719.
[Full text]
[PDF]
- ARTICLES
Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians
- F. R. Guerini, P. Ferrante, L. Losciale, D. Caputo, M. L. Lombardi, G. Pirozzi, V. Luongo, M. A. Sudomoina, T. V. Andreewski, A. D. Alekseenkov, A. N. Boiko, E. I. Gusev, and O. O. Favorova
Neurology 2003; 61: 520-526.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Interrupted therapy: Stopping and switching of the ß-interferons prescribed for MS
- Helen L. Tremlett and Joel Oger
Neurology 2003; 61: 551-554.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Clinical characteristics of responders to interferon therapy for relapsing MS
- E. Waubant, S. Vukusic, L. Gignoux, F. Durand- Dubief, I. Achiti, S. Blanc, C. Renoux, and C. Confavreux
Neurology 2003; 61: 184-189.
[Abstract]
[Full text]
[PDF]
|
|
